Machine learning on the road to unlocking microbiota's potential for boosting immune checkpoint therapy

Area of Science:

• Microbiome research
• Bioinformatics
• Oncology

Background:

• The human gut microbiome plays a crucial role in health and disease, with dysbiosis linked to various pathologies.
• Understanding host-microorganism interactions is challenging due to complex biological systems.
• Traditional bioinformatics tools struggle with the large datasets generated by modern high-throughput sequencing.

Purpose of the Study:

• To review analytical approaches for investigating the gut microbiome's role in immune checkpoint therapy (ICT).
• To highlight the potential of Machine Learning (ML) in analyzing complex microbiome data.
• To explore the application of shotgun metagenomic sequencing (SMS) data in this field.

Main Methods:

• Review of analytical strategies for gut microbiome data.
• Focus on Machine Learning (ML) applications.
• Examination of shotgun metagenomic sequencing (SMS) data analysis.

Main Results:

• Machine learning offers a promising approach to overcome limitations of traditional bioinformatics tools for big data analysis.
• Shotgun metagenomic sequencing (SMS) data is crucial for detailed microbiome analysis.
• Growing evidence links gut microbiome composition to cancer development and treatment outcomes.

Conclusions:

• Advanced analytical methods, including ML, are vital for deciphering the gut microbiome's impact on human health.
• The gut microbiome holds potential for developing novel diagnostics and therapeutics, particularly in oncology.
• Further research into microbiome-host interactions is anticipated to advance cancer treatment strategies.